Uncategorized
FDA grants marketing approval for generic Lumigan
Lupin Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration to market a generic version of Allergan’s Lumigan in the U.S.This approval to market bimatoprost ophthalmic solution 0.03% follows a January FDA audit of the company’s Indore, India, facility where the product was made, according to a company press release.